- Home
- TRVI vs PFL Comparison
TRVI vs PFL Comparison
Compare TRVI & PFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- PFL
- Stock Information
- Founded
- TRVI 2011
- PFL 2003
- Country
- TRVI United States
- PFL United States
- Employees
- TRVI N/A
- PFL N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- PFL Finance Companies
- Sector
- TRVI Health Care
- PFL Finance
- Exchange
- TRVI Nasdaq
- PFL Nasdaq
- Market Cap
- TRVI 341.4M
- PFL 329.9M
- IPO Year
- TRVI 2019
- PFL N/A
- Fundamental
- Price
- TRVI $4.24
- PFL $8.50
- Analyst Decision
- TRVI Strong Buy
- PFL
- Analyst Count
- TRVI 8
- PFL 0
- Target Price
- TRVI $9.31
- PFL N/A
- AVG Volume (30 Days)
- TRVI 454.6K
- PFL 113.7K
- Earning Date
- TRVI 03-19-2025
- PFL 01-01-0001
- Dividend Yield
- TRVI N/A
- PFL 11.53%
- EPS Growth
- TRVI N/A
- PFL N/A
- EPS
- TRVI N/A
- PFL N/A
- Revenue
- TRVI N/A
- PFL N/A
- Revenue This Year
- TRVI N/A
- PFL N/A
- Revenue Next Year
- TRVI N/A
- PFL N/A
- P/E Ratio
- TRVI N/A
- PFL N/A
- Revenue Growth
- TRVI N/A
- PFL N/A
- 52 Week Low
- TRVI $1.39
- PFL $6.98
- 52 Week High
- TRVI $4.68
- PFL $8.62
- Technical
- Relative Strength Index (RSI)
- TRVI 60.00
- PFL 57.25
- Support Level
- TRVI $3.81
- PFL $8.38
- Resistance Level
- TRVI $4.04
- PFL $8.45
- Average True Range (ATR)
- TRVI 0.25
- PFL 0.05
- MACD
- TRVI -0.00
- PFL 0.00
- Stochastic Oscillator
- TRVI 90.89
- PFL 87.50
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About PFL PIMCO Income Strategy Fund Shares of Beneficial Interest
PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. It seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.